Meet the developers behind the Pfizer building conversion
New York City turned its eyes towards the former Pfizer building in Midtown East Tuesday morning, but not for the reason the developers would’ve hoped. Reports emerged before 8 a.m. of debris falling from the construction site at 235 East 42nd Street, arguably the country’s most notable office-to-residential conversion post-pandemic to unfold. As of midday, concerns about the safety of the building remain as columns within the building buckle, forcing evacuations and street closures in and around the property. It’s not the first notable incident at the project, which commanded real estate’s attention long before pedestrians were forced to steer […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts
New York City halts office-to-resi conversion at 222
Broadway
DOJ launches criminal investigation into camps owner Simad
Holdings, David and Michael Shabsels
Deal Diary: 9 Years, 39 Doors, and $20K a Month in Cash
Flow—Here’s How Jefferson Simmons Built His Portfolio
One Rental Property Saved Me From My 100-Hour
Workweeks
The “Repeatable” Strategy That Helped Him Buy 6 Rentals in 6
Months (Working 9-5)
Cash Flow vs. Appreciation: What Should Beginners Focus on?
(Rookie Reply)
6 Reasons Why Buyers Walk Away After Touring a Home
Location vs Property Size: What Matters More When Buying a
Home?
Low-Maintenance Living: Top Features That Make a Home Easier
to Maintain
Rybak bucks 485x slump with 500-unit Coney Island
development
